Seller record · Telehealth service

Mojoon

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 3 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named. The product pages refer only to FDA-certified 503A and 503B pharmacies and to local partner pharmacies, and the terms to pharmacy services. 2 more criteria also fail; see the table below.

At a glance

MojoonTelehealth service

5/8criteria passed

Price: Compounded semaglutide $350 to $520 a month, was $1,000
Sells: compounded semaglutide injections, compounded tirzepatide injections, and 11 more
FDA letters: None on file

Visit Mojoon See all eight dispositions

Telehealth service. Passes 5 of 8 criteria. Recorded against Standard v1.1.

A Chinese-language telehealth service for Chinese speakers in the United States, selling compounded semaglutide and tirzepatide injections, oral semaglutide drops and wellness injections, and prescribing erectile dysfunction, hair loss and antiviral medicines. Care starts with an online medical questionnaire reviewed by a licensed doctor, and no pharmacy is named.

Operating entity Mojoon Inc

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Mojoon's 司美格鲁肽 semaglutide page; Mojoon's terms and conditions
S2	Prescription gating	PASS	Mojoon's aboutmojoon 关于我们 page; Mojoon's 司美格鲁肽 semaglutide page
S3	Pharmacy identification	FAIL	Mojoon's 司美格鲁肽 semaglutide page; Mojoon's terms and conditions
S4	Compounding disclosure	FAIL	Mojoon's 口服司美格鲁肽 semaglutide oral page; Mojoon's 司美格鲁肽 semaglutide page
S5	Analytical documentation	FAIL	Mojoon's 司美格鲁肽 semaglutide page; Mojoon's terms and conditions
S6	Business address	PASS	Mojoon's terms and conditions; Mojoon's contact 联系我们 page
S7	Price disclosure	PASS	Mojoon's 司美格鲁肽 semaglutide page; Mojoon's 替尔泊肽 tirzepatide page; Mojoon's website
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA licensed doctor reviews each questionnaire and writes the prescription within 24 hours, and the terms name Beluga Health, P.A. and affiliated professional entities as the providers.Source: Mojoon's 司美格鲁肽 semaglutide page; Mojoon's terms and conditions.

S2PASSThe steps printed on the about and product pages are to register and complete the medical questionnaire, then choose a treatment plan and pay, then have a licensed doctor review the prescription within 24 hours before delivery.Source: Mojoon's aboutmojoon 关于我们 page; Mojoon's 司美格鲁肽 semaglutide page.

S3FAILNo filling pharmacy is named. The product pages refer only to FDA-certified 503A and 503B pharmacies and to local partner pharmacies, and the terms to pharmacy services.Source: Mojoon's 司美格鲁肽 semaglutide page; Mojoon's terms and conditions.

S4FAILThe oral semaglutide drops page calls the compounded product an FDA-approved GLP-1 agonist, and the injection pages describe semaglutide as FDA-approved with fully verified safety and say the compounded product has the same active ingredient as Ozempic and Wegovy, although they also say compounded drugs are not subject to FDA approval.Source: Mojoon's 口服司美格鲁肽 semaglutide oral page; Mojoon's 司美格鲁肽 semaglutide page.

S5FAILNo certificate of analysis or lot document is published on the product pages, the answers or the terms.Source: Mojoon's 司美格鲁肽 semaglutide page; Mojoon's terms and conditions.

S6PASSMojoon Inc at 861 South Village Oaks Drive, Suite 204, Covina, California 91724, printed in the terms; the contact page gives the same street address.Source: Mojoon's terms and conditions; Mojoon's contact 联系我们 page.

S7PASSCompounded semaglutide costs $350 to $520 for a monthly course of four weekly injections and compounded tirzepatide $390 to $490, each printed beside a struck-through $1,000, and oral semaglutide drops cost $400 a month beside a struck-through $900. NAD+ injections cost $290, glutathione injections $369, sildenafil from $80 and finasteride from $1 a pill.Source: Mojoon's 司美格鲁肽 semaglutide page; Mojoon's 替尔泊肽 tirzepatide page; Mojoon's website.

S8PASSNo FDA warning letter names Mojoon or Mojoon Inc, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide injections, compounded tirzepatide injections, compounded oral semaglutide drops, NAD+ injections, glutathione injections, Lipo-B injections, B12 injections, sildenafil and tadalafil, sertraline, valacyclovir, finasteride, Latisse, Paxlovid.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells NAD+Who sells glutathione

Visit Mojoon

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.